MMP-2, MMP-9 and their inhibitors TIMP-2 and TIMP-1 production by human monocytes in vitro in the presence of different forms of hydroxyapatite particles. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Biomaterials Année : 2004

MMP-2, MMP-9 and their inhibitors TIMP-2 and TIMP-1 production by human monocytes in vitro in the presence of different forms of hydroxyapatite particles.

Résumé

After calcium-phosphates biomaterials based implantation like hydroxyapatite (HA) coating, particles are released in the periprosthetic tissues. Wear-debris induced fibrous membranes contain macrophage subsets that can produce metalloproteinases (MMPs), which are considered to be key enzymes in extra-cellular matrix turnover. Tissue inhibitors of metalloproteinases (TIMPs) are important regulator of MMPs activity. Interleukin-1 mainly produced by monocytes can also regulate MMPs production. In the present work, we have evaluated the effect of HA particles characteristics (size, shape and sintering temperature) on the MMP-2, -9 and their respective inhibitors TIMP-2, -1 production. Our results demonstrate that sintering temperature (that modify crystal size and surface area) have little effect on MMPs and TIMPs production. Non-phagocytable particles induced more MMP-9, although phagocytable particles induced more IL-1β release. The shape of the particles was the most important factor since needle-shaped particles induced the most significant up-regulated expression of MMPs and IL-1β.
Fichier principal
Vignette du fichier
MMP_TIMPs_5_Biomat.pdf (431.11 Ko) Télécharger le fichier
Loading...

Dates et versions

inserm-00068633 , version 1 (06-06-2006)

Identifiants

  • HAL Id : inserm-00068633 , version 1
  • PUBMED : 14751736

Citer

Patrice Laquerriere, Alexia Grandjean-Laquerriere, Salima Addadi-Rebbah, Edouard Jallot, Dominique Laurent-Maquin, et al.. MMP-2, MMP-9 and their inhibitors TIMP-2 and TIMP-1 production by human monocytes in vitro in the presence of different forms of hydroxyapatite particles.. Biomaterials, 2004, 25 (13), pp.2515-24. ⟨inserm-00068633⟩
167 Consultations
2823 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More